391 related articles for article (PubMed ID: 29653575)
21. The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.
Meshram CD; Baviskar PS; Ognibene CM; Oomens AGP
J Virol; 2016 Dec; 90(23):10612-10628. PubMed ID: 27654298
[TBL] [Abstract][Full Text] [Related]
22. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
23. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
24. High-throughput characterization of virus-like particles by interlaced size-exclusion chromatography.
Ladd Effio C; Oelmeier SA; Hubbuch J
Vaccine; 2016 Mar; 34(10):1259-67. PubMed ID: 26845741
[TBL] [Abstract][Full Text] [Related]
25. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
26. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
27. Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases.
Klamp T; Schumacher J; Huber G; Kühne C; Meissner U; Selmi A; Hiller T; Kreiter S; Markl J; Türeci Ö; Sahin U
Cancer Res; 2011 Jan; 71(2):516-27. PubMed ID: 21224362
[TBL] [Abstract][Full Text] [Related]
28. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
29. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
Mihailova M; Boos M; Petrovskis I; Ose V; Skrastina D; Fiedler M; Sominskaya I; Ross S; Pumpens P; Roggendorf M; Viazov S
Vaccine; 2006 May; 24(20):4369-77. PubMed ID: 16574285
[TBL] [Abstract][Full Text] [Related]
30. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
31. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
[TBL] [Abstract][Full Text] [Related]
33. Characterization and diagnostic potential of hepatitis B virus nucleocapsid expressed in E. coli and P. pastoris.
Watelet B; Quibriac M; Rolland D; Gervasi G; Gauthier M; Jolivet M; Letourneur O
J Virol Methods; 2002 Jan; 99(1-2):99-114. PubMed ID: 11684308
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles.
Lu T; Behloul N; Zhou Y; Baha S; Liu Z; Wei W; Shi RH; Meng J
Intervirology; 2022; 65(1):37-48. PubMed ID: 34695827
[TBL] [Abstract][Full Text] [Related]
35. High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors.
Diamos AG; Mason HS
Protein Expr Purif; 2018 Nov; 151():86-92. PubMed ID: 29908914
[TBL] [Abstract][Full Text] [Related]
36. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
37. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
Li TC; Takeda N; Miyamura T; Matsuura Y; Wang JC; Engvall H; Hammar L; Xing L; Cheng RH
J Virol; 2005 Oct; 79(20):12999-3006. PubMed ID: 16189002
[TBL] [Abstract][Full Text] [Related]
38. Virus-Like Particles Produced Using the Brome Mosaic Virus Recombinant Capsid Protein Expressed in a Bacterial System.
Strugała A; Jagielski J; Kamel K; Nowaczyk G; Radom M; Figlerowicz M; Urbanowicz A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803568
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional structure of the hepatitis B core antigen particle truncated at residue 154.
Liu S; He J; Li K; Dai A; Cai C; Zhang J
Sci China Life Sci; 2011 Feb; 54(2):171-4. PubMed ID: 21104034
[TBL] [Abstract][Full Text] [Related]
40. Ensembles of Hydrophobicity Scales as Potent Classifiers for Chimeric Virus-Like Particle Solubility - An Amino Acid Sequence-Based Machine Learning Approach.
Vormittag P; Klamp T; Hubbuch J
Front Bioeng Biotechnol; 2020; 8():395. PubMed ID: 32432098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
